Some Claims In Price-Fixing Stock-Drop Suit Against Generic Drug Maker Remanded

Mealey's (January 14, 2021, 8:54 AM EST) -- SAN FRANCISCO — Although a federal district court erred in dismissing several of a pension fund’s claims in a securities class action lawsuit against a drug maker and certain of its current and former executive officers, it correctly determined that certain of the investor’s claims were insufficiently pleaded pursuant to federal securities laws, a Ninth Circuit U.S. Court of Appeals panel ruled Jan. 11....